Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Minimally Invasive, Single-Stage, Multilevel Surgery for Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis Publisher Pubmed



Rahaviezabadi S1 ; Su YY2, 3 ; Wang YH4 ; Lin CW2, 5 ; Chang CT6 ; Friedman M7, 8 ; Salapatas AM8 ; Amali A9 ; Lin HC2, 3, 6, 10
Authors
Show Affiliations
Authors Affiliations
  1. 1. Otorhinolaryngology Research Center, Otorhinolaryngology Head and Neck Surgery Department, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
  3. 3. Sleep Center and Robotic Surgery Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
  4. 4. School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
  5. 5. Department of Education, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
  6. 6. Department of Business Management, Institute of Healthcare Management, Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan
  7. 7. Department of Otolaryngology, Division of Sleep Surgery, Rush University Medical Center, Chicago, IL, United States
  8. 8. Department of Otolaryngology, Advanced Center for Specialty Care, Advocate Illinois Masonic Medical Center, Chicago, IL, United States
  9. 9. Sleep Breathing Disorders Research Center (SBDRC), Occupational Sleep Research Center (OSRC), Otorhinolaryngology Research Center, Otorhinolaryngology Head and Neck Surgery Department, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Center for Quality Management Kaohsiung Chang Gung Memorial Hospital, Kaohsiung
  11. 11. College of Medicine, Chang Gung University, Taoyuan, Taiwan

Source: Clinical Otolaryngology Published:2023


Abstract

Objectives: Minimally invasive, single-staged multilevel surgery (MISS MLS) could be an optimal treatment for selected patients with obstructive sleep apnea (OSA). We aim to systematically review the efficacy of MISS MLS for patients with OSA, as well as the clinical outcomes and possible complications in OSA patients before and after MISS MLS. Design and setting: Systematic review and meta-analysis. Six databases were searched, and the PRISMA guideline was followed. Participants: Patients with OSA receiving MISS MLS. Main outcome measures: The random-effects model was adopted for the statistical synthesis. The percentage and 95% confidence interval (CI) were adopted as the effect measurements of MISS MLS for OSA. Subgroup analyses and sensitivity analyses were also performed to identify the heterogeneity among the studies. Results: There were initially 154 articles for identification. Eventually, six studies with a total of 848 OSA patients completely met the inclusion criteria and were further enrolled for analysis. The pooled analysis showed statistically significant lower AHI (apnea/hypopnea index, /hr.; mean difference: −8.931, 95% CI: −11.591 to −6.271, I2 = 87.4%), ESS (mean difference: −2.947, 95% CI: −4.465 to −1.429, I2 = 94.9%), and snoring severity with 0-10 visual analog scale after surgery (mean difference: −4.966, 95% CI: −5.804 to −4.128, I2 = 96.4%). The success rate was 46% in mild/moderate OSA; however, 18% in severe OSA. There were no major complications occurred. Conclusions: The acceptable surgical outcomes, esp. in mild/moderate OSA, and rare complications are the major advantages of MISS MLS. The evidence of this study could aid the decision making in selecting suitable treatment programs for OSA patients. © 2023 John Wiley & Sons Ltd.
Related Docs
1. Inflammatory Biomarkers of Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios in 563 Severe Osa Patients Before and After Surgery, Journal of Otolaryngology - Head and Neck Surgery (2023)